![John F. Chin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John F. Chin
Directeur/Membre du Conseil chez ANTENGENE CORPORATION LIMITED
Fortune : 182 385 $ au 30/06/2024
Profil
John F.
Chin is currently the Executive Director & Chief Business Officer at Antengene Corporation Co., Ltd.
and Antengene Corp.
Ltd.
He previously worked as the Senior Director-Corporate Accounting Management at Celgene Corp.
from 2005 to 2020.
Prior to that, he was an Associate Product Manager at Aventis Pharmaceuticals, Inc. starting in 1998.
Mr. Chin holds an MBA from Pepperdine University, which he received in 1998, and an undergraduate degree from the University of Arizona, which he received in 1989.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
11/11/2022 | 1 825 496 ( 0,27% ) | 182 385 $ | 30/06/2024 |
Postes actifs de John F. Chin
Sociétés | Poste | Début |
---|---|---|
ANTENGENE CORPORATION LIMITED | Directeur/Membre du Conseil | 18/08/2020 |
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/10/1998 |
Antengene Corporation Co., Ltd.
![]() Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | - |
Anciens postes connus de John F. Chin
Sociétés | Poste | Fin |
---|---|---|
CELGENE | Corporate Officer/Principal | 01/01/2020 |
Formation de John F. Chin
University of Arizona | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ANTENGENE CORPORATION LIMITED | Health Technology |
Entreprise privées | 3 |
---|---|
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
![]() Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |